Clever Leaves Holdings Inc (CLVR)
1.540
-0.02
(-1.57%)
USD |
NASDAQ |
May 01, 16:00
1.54
0.00 (0.00%)
Pre-Market: 08:24
Clever Leaves Holdings Total Return Level: 1.540 for May 1, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 01, 2024 | 1.540 |
April 30, 2024 | 1.565 |
April 29, 2024 | 1.62 |
April 26, 2024 | 4.11 |
April 25, 2024 | 3.872 |
April 24, 2024 | 3.93 |
April 23, 2024 | 3.88 |
April 22, 2024 | 3.835 |
April 19, 2024 | 4.081 |
April 18, 2024 | 4.095 |
April 17, 2024 | 4.23 |
April 16, 2024 | 4.540 |
April 15, 2024 | 4.635 |
April 12, 2024 | 4.53 |
April 11, 2024 | 5.023 |
April 10, 2024 | 4.92 |
April 09, 2024 | 4.808 |
April 08, 2024 | 4.86 |
April 05, 2024 | 5.10 |
April 04, 2024 | 5.195 |
April 03, 2024 | 5.32 |
April 02, 2024 | 5.05 |
April 01, 2024 | 5.03 |
March 28, 2024 | 4.87 |
March 27, 2024 | 4.90 |
Date | Value |
---|---|
March 26, 2024 | 4.93 |
March 25, 2024 | 4.46 |
March 22, 2024 | 4.60 |
March 21, 2024 | 3.510 |
March 20, 2024 | 3.90 |
March 19, 2024 | 3.90 |
March 18, 2024 | 3.69 |
March 15, 2024 | 3.33 |
March 14, 2024 | 3.38 |
March 13, 2024 | 3.444 |
March 12, 2024 | 3.520 |
March 11, 2024 | 3.31 |
March 08, 2024 | 3.310 |
March 07, 2024 | 3.55 |
March 06, 2024 | 3.71 |
March 05, 2024 | 3.67 |
March 04, 2024 | 3.90 |
March 01, 2024 | 4.272 |
February 29, 2024 | 4.11 |
February 28, 2024 | 4.10 |
February 27, 2024 | 4.180 |
February 26, 2024 | 4.21 |
February 23, 2024 | 4.30 |
February 22, 2024 | 3.61 |
February 21, 2024 | 3.76 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.540
Minimum
May 01 2024
576.00
Maximum
Feb 16 2021
99.20
Average
25.55
Median
Total Return Level Benchmarks
Tilray Brands Inc | 2.02 |
Flora Growth Corp | 1.711 |
Acasti Pharma Inc | 2.850 |
Aurinia Pharmaceuticals Inc | 5.20 |
Edesa Biotech Inc | 4.452 |